Risky Business: Assessing Protein Aggregation Grows Increasingly Challenging: Current and newer biologic modalities pose increasingly complex challenges to the detection and characterization of protein aggregates.
| Publicado en: | BioPharm International pp. 35 - 39 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Sep2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146487735&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 146487735 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Sep2020 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 146487735 146487735 ppf: 35 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Risky Business: Assessing Protein Aggregation Grows Increasingly Challenging: Current and newer biologic modalities pose increasingly complex challenges to the detection and characterization of protein aggregates. aug: au: MIRASOL, FELIZA sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|